CAPPED BONUSZERTIFIKAT - STRYKER CORP. Stock

Certificat

DE000PC5RT85

Real-time Boerse Frankfurt Warrants 09:20:37 2024-05-13 am EDT
322.8 EUR +0.01% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-0.77%
1 month-2.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-13 322.8 +0.01% 0
24-05-10 322.8 +0.41% 0
24-05-09 321.5 +0.65% 0
24-05-08 319.4 -0.97% 0
24-05-07 322.5 +2.06% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 09:20 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RT8
ISINDE000PC5RT85
Date issued 2024-02-27
Strike 400 $
Maturity 2024-12-20 (221 Days)
Parity 1 : 1
Emission price 322.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 335.1
Lowest since issue 312.3

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW